To develop a drug or treatment for Parkinson’s disease observational study is being conducted by a scientist in a laboratory to provide patients with a better life. Clinical trials are performed to slow down the rate of suffering and reduce the symptoms. There is no cure for PD as far, butresearchers improved more treatment. Trails help to reduce the risk factors. Trail sari the best way to find out whether a new treatment is safe, is a benefit to patients, is more effective, is that improving the quality of life with PD
Clinical research is an expensive process which requires strong financial support. This comes from a range of sponsors including thepharmaceutical industries, Governments, Researchers, and Organizations.
Related: Parkinson’s Conference | Parkinson’s Congress | Parkinson’s Disorder Congress | Movement Disorder Conferences | Neuroscience Conference | Neurology Conference
Related Conferences:
6th World Congress on Parkinson’s & Huntington Disease, September 20-21,2020 at Rome, Italy | International Congress of Parkinson's Disease and Movement Disorders, September 13-17,2020, at Philadelphia, USA | 6th World Parkinson Congress, June 7-10, 2022 atBarcelona, Spain | 7th International Congress on Parkinsons and Movement Disorders, November 14-15,2019 at London, UK | 29th World Congress on Neurology and Therapeutics, February 24-25, 2020 at London, UK
Related Association and Societies:
American Academy of Neurology; Movement Disorders Society; The International Parkinson and Movement Disorder Society; Canadian Movement Disorders Group; UK Parkinson’s Action Network; European Neurological Society; European Parkinson’s Disease Association; Danish Movement Disorder Society; Italian Society for the study of Parkinson Disease; Extrapyramidal Diseases and Dementia; Movement Disorder Society of Australia; Parkinson’s Disease and Movement Disorders Society of India; Australian Parkinson’s Disease Society; Movement Disorder Society of Japan